A SHOWCASE AND CELEBRATION OF OUR
2024 GRADUATING STARTUPS
Director’s Note
Welcome to Frontiers 2024. We are thrilled that you’ve joined us to celebrate the progress of our 2023-2024 cohort of startups.
At Endless Frontier Labs (EFL), we are dedicated to advancing human welfare through science and technology-based entrepreneurship. Our nine-month program for seed-stage founders provides mentorship from industry leaders, access to investors and customers, and business development support from MBA students in NYU Stern’s top-ranked MBA program.
Despite the strong headwinds facing the venture industry this past year, EFL graduates have continued to thrive. Notably, BreachQuest (Digital Tech ‘23), a cybersecurity company that bolsters enterprises’ incident response mechanisms against cyber attacks was acquired by Resilience, a leading cyber risk management firm, and Haystack Oncology (Life Science ‘23), a cancer detection company, was acquired by Quest Diagnostics in a $450M deal.Since 2019, the EFL process has helped its 183 startup graduates raise$1.83 billion with a combined valuation of $5.04 billion.Based on this number, and other key metrics of accelerator success like fraction of startups that successfully raise, and frequency of high-value startups, the EFL stands without peer among programs that serve deep tech and science based companies.
This year’s cohort of 55 graduating companies were selected from a pool of nearly 1,400 applicants from over 60 countries worldwide.The founders of these startups, with the guidance of EFL mentors, have made excellent progress in building their businesses over the past nine months and are poised to disrupt various industries, including drug discovery, energy, logistics, enterprise security, space, and healthcare delivery. You can explore brief descriptions of each company on our website or in the program booklet.
Frontiers 2024 will feature the latest from these companies in a format that is designed to provide a vantage of the latest in science, technology and industry. Come, join us on May 9 to celebrate EFL’s 2023-24cohort and immerse yourself in a showcase of our collective future.
Deepak Hegde
Founder and Andrew Hamilton Director, Endless Frontier Labs
Seymour Milstein Professor of Strategy, NYU Stern School of Business
PROGRAM
MAY 9, 2024
Welcome Address
Panel: Unlocking the Power of Big Data & Biology
Panel: Breakthrough Treatments for Unmet Needs
Startup Presentations: Oncology and Immune Therapies
Startups:
- Glytherix
- Avstera Therapeutics
- Tezcat Biosciences
- Calder Biosciences
- Vector Bioscience
- Atticus Pharma
- Matrisome Bio
Startup Presentations: Central Nervous System and Regenerative Medicine
Startups:
- 4M Therapeutics
- Imnewrun
- Kanna Health
- Ambulero
- Eucalyptus Bio
- InGel Therapeutics
Panel: Frontier Tech Applications and Impact
Startup Presentations: Advanced Materials and Sustainability
Startups:
- Strayos
- BIOWEG
- GreenPod Labs
- Soliyarn
- Cocoon Bioscience
- Circu Li-ion
- INAEDIS
- Direct Kinetic Solutions
Startup Presentations: Automation, Robots, and Rockets
Startups:
- Zordi
- Fire Neural Network
- Kyber Labs
- Rocket Propulsion Systems
- Sinovia Technologies
Panel: Digital Health Solutions for Patients & Providers
Panel: Enterprise AI and the Future of Work
Startup Presentations: AI for Data Analytics and Cybersecurity
Startups:
- Bilby
- SURF Security
- Quantum Bridge Technologies
- DeepKeep
- Digip
- Fr0ntierX
Liz Elting Awards & Reception
Startup Presentations: Oncology and Immune Therapies
- Glytherix
- Avstera Therapeutics
- Tezcat Biosciences
- Calder Biosciences
- Vector Bioscience
- Atticus Pharma
- Matrisome Bio
Startup Presentations: Central Nervous System and Regenerative Medicine
- 4M Therapeutics
- Imnewrun
- Kanna Health
- Ambulero
- Eucalyptus Bio
- InGel Therapeutics
Startup Presentations: Advanced Materials and Sustainability
- Strayos
- BIOWEG
- GreenPod Labs
- Soliyarn
- Cocoon Bioscience
- Circu Li-ion
- INAEDIS
- Direct Kinetic Solutions
Startup Presentations: Automation, Robots, and Rockets
- Zordi
- Fire Neural Network
- Kyber Labs
- Rocket Propulsion Systems
- Sinovia Technologies
Startup Presentations: AI for Data Analytics and Cybersecurity
- Bilby
- SURF Security
- Quantum Bridge Technologies
- DeepKeep
- Digip
- Fr0ntierX
SPEAKERS
Ade Ajanaku
Senior Product Manager at Intuit
Amir Reuveny
CEO of Wesper (EFL Digital Tech ‘20)
Asad Malik
CEO of iRocket (EFL Deep Tech ‘21
Asaf Zviran
Co-Founder & CEO Prism AI Therapeutics (EFL Life Sciences...
Brenton Fargnoli
Managing Partner, AlleyCorp
Bruce Zetter
Charles Nowiszewski Professor of Cancer Biology, Harvard Medical School
Chris Ho
Director, Vickers Venture Partners
David Fenyö
Professor, Computational Biology, NYU Langone Health
Devin Mann
Prof. of Population Health & Medicine, Strategic Director, Digital...
Dillon Baxter
Founder and CEO of PlantSwitch (EFL Deep Tech ‘23)
Elizabeth Elting
Founder and CEO, Elizabeth Elting Foundation & Stern MBA...
Foster Provost
Ira Rennert Professor of Entrepreneurship, Data Science, and Information...
Jill Richmond
GP, Full Stack VC
Laura Kornhauser
Co-founder & CEO, Stratyfy (EFL Deep Tech ‘20)
Mathew Barnett
CEO of UbiquiTx (EFL Life Sciences ‘23)
Nil Gural
Senior Associate, Polaris Partners
Prakrit Jena
Co-Founder and CTO of Lime Therapeutics (EFL Life Sciences...
Rachael-Linn Spooner
VP Strategic Planning, Clinical Digital Solutions, Northwell Health
Rana Al-Hallaq
Partner, Pfizer Ventures and Executive Director, Worldwide Business Development,...
Sarah Dolman
Partner, Recon Strategy
Sebastian Titz
Investment Manager, 3M New Ventures
Seth Neel
Assistant Professor at Harvard Business School
Tarek Ali Zaki
CEO of OncoPrecision (EFL Life Sciences ‘22)
Toby Stuart
Helzel Professor, UC Berkeley-Haas
Vanessa Rissetto
CEO & Co-founder of Culina Health (EFL Digital Tech...
2024 GRADUATES
4M Therapeutics
FUNDRAISING
4M Therapeutics is developing targeted therapies for neurological and psychiatric disorders using its living human brain cell drug discovery platform. The lead asset is safer and more potent than lithium, the current standard of care for bipolar disorder.
Akool
FUNDRAISING
AKOOL is a Generative AI platform for personalized visual marketing and advertising.
Ambulero
FUNDRAISING
Ambulero is advancing new cell and gene therapy products to treat patients with advanced vascular disease and non-healing wounds, where the standard of care is often amputation.
Ataraxis AI
Ataraxis AI is developing prognostic and predictive digital diagnostic assays that integrate multi-modal data to deliver accurate, patient-specific predictions about therapeutic outcomes across several diseases, starting with early-stage breast cancer.
Atticus Pharma
Atticus Pharma is improving the bioavailability and effectiveness of topically applied drugs for a range of indications, including lupus and alopecia, with its proprietary sustained-release technology.
Augmenta
Augmenta delivers construction design software that generates compliant, sustainable building designs that saves time and money for customers and reduces errors and the need for manual rework.
Avstera Therapeutics
FUNDRAISING
Avstera Therapeutics is a clinical-stage oncology company tackling key immunological challenges seen in the tumor microenvironment with its oral HDAC6 inhibitor for advanced cancer patients who fail to respond to existing therapies.
Aware Health
FUNDRAISING
Aware Health diagnoses wear and tear orthopedic conditions without imaging and treats them without surgery.
Bilby
Bilby predicts, tracks, and decodes government activity worldwide using AI.
BIOWEG
FUNDRAISING
BIOWEG leverages fermentation, materials science, and green chemistry to replace microplastics in cosmetics, personal care, and agricultural coatings using a zero-waste circular process.
Calder Biosciences
FUNDRAISING
Calder Biosciences is developing the next-generation of recombinant protein vaccines with its patented 3D-Vaxlock™ technology, driving increased potency and more durable protection against infectious diseases.
Circu Li-ion
FUNDRAISING
Circu Li-ion enables the economical reuse of battery packs by developing automated upcycling solutions using robotics and AI.
Cocoon Bioscience
Cocoon Bioscience produces critical enzymes and proteins using a novel expression system that leverages insect cocoons as natural bioreactors, offering performance and cost advantages over traditional methods.
Cooler Heads
FUNDRAISING
Cooler Heads provides cancer patients and care providers with FDA-cleared products, content, and services for the management of side effects of treatment.
DeepKeep
FUNDRAISING
DeepKeep empowers large corporates that rely on AI, GenAI, and LLM to manage risk and protect growth.
Digip
FUNDRAISING
Digip provides startups and SMEs with an automated trademark filing and protection service that streamlines the trademark protection process.
Direct Kinetic Solutions
FUNDRAISING
Direct Kinetic Solutions strives to decarbonize the energy sector using high-energy-density radioisotopes to create self-sustaining, long-lasting power sources that combine the persistence and reliability of a power plant with the convenience and mobility of a battery the size of a stamp.
Eucalyptus Bio
FUNDRAISING
Eucalyptus Bio is enabling the treatment of hundreds of currently unaddressable genetic diseases using its long-range gene editing platform (CRISP-HR) to permanently correct multiple disease causing mutations within an unparalleled genome edit window.
Fire Neural Network
FUNDRAISING
Fire Neural Network uses AI to detect wildfires, processing lightning data gathered by patented ground-based sensors to identify high-risk lightning and probable ignition points. The hotspots are then validated with a proprietary US-made drone.
Fr0ntierX
FUNDRAISING
Fr0ntierX provides enterprises with cybersecurity and access management by utilizing emerging technologies to secure and encrypt data in all stages, allowing for granular-level data insights and user privacy.
Gigantor
FUNDRAISING
Gigantor optimizes artificial intelligence performance for edge mobility devices with a multi-patented circuit-generating system for FPGAs and ASICs.
GlyTherix
FUNDRAISING
GlyTherix is a clinical-stage targeted radiotherapy company developing a first-in-class therapeutic antibody to treat solid tumors expressing Glypican-1 (GPC-1), a cell surface target that occurs within many solid tumors including prostate, bladder & pancreatic cancers.
GreenPod Labs
FUNDRAISING
GreenPod Labs is an Agtech startup developing products to extend the shelf life of fruits and vegetables at ambient temperature during transport and storage.
IMNEWRUN
FUNDRAISING
IMNEWRUN is developing a novel blood-brain barrier penetrating antibody platform and therapeutic pipeline for patients with brain-related diseases, starting with Alzheimer's disease.
INAEDIS
INAEDIS aims to disrupt pharmaceutical cold-chain logistics by enabling the thermal stabilization of heat- and freeze-sensitive biologics at room temperature, using a technology that converts liquid biologics into room-temperature stable powders with proprietary dehydration equipment.
InGel Therapeutics
FUNDRAISING
InGel Therapeutics is developing bioengineered cell therapies to bring back light to patients suffering from all forms of retinal degeneration and blindness.
Kanna Health
FUNDRAISING
Kanna Health is a clinical-stage biotech looking to bridge the 'intimacy gap' by developing an on-demand solution for premature ejaculation, for which there is currently no FDA-approved treatment.
Knowtex
Knowtex empowers clinicians with voice AI workflows to generate accurate notes, coding, and orders tailored by specialty to clinical conversations, empowering clinicians to save hours each day, capture revenue leakage, and focus on patient care.
Kyber Labs
Kyber Labs tackles manual labor shortages with a robotic manipulation platform designed for AI-based controls, leveraging novel and unique artificial fiber-based actuators that mimic human muscle, thus enabling natural movements not possible with traditional systems.
Maestro AI
FUNDRAISING
Maestro increases development team velocity and alignment by automatically creating status updates, updating documentation, and helping people stay in sync through a generative AI powered platform.
Matrisome Bio
Matrisome Bio is leveraging a new target, the disease-associated extracellular matrix, to develop nanobodies for highly targeted delivery of therapeutic payloads to a range of chronic disease sites, including tumors, metastases, and fibrotic lesions.
Moody Month
FUNDRAISING
Moody improves mental and physical health for women by connecting their hormone health data with actionable support.
Narrativa
FUNDRAISING
Narrativa provides AI-automation for clinical trial regulatory documentation and data analysis, helping clients reduce the time and cost spent on regulatory documentation.
OraLiva
FUNDRAISING
OraLiva is reshaping the future of oral health through early detection with its AI-based, first-in-class, clinically validated oral cancer adjunctive test.
OxiWear
FUNDRAISING
OxiWear develops wearables for continuous oxygen monitoring, delivering low-oxygen alerts during still and motion to enhance safety, reduce healthcare costs, and save lives for those vulnerable to silent hypoxia.
Pando Bioscience
FUNDRAISING
Pando Biosciences is a synthetic biology company transforming active pharmaceutical ingredients production by developing high-performance enzymes using Generative AI and its proprietary ultra-high-throughput screening platform, ultimately reducing costs and improving productivity.
Promise Bio
Promise Bio is uncovering new biological insights to advance precision medicine for immune-mediated diseases by performing broad epiproteomic analysis using a proprietary computational platform.
Quanmol Tech
FUNDRAISING
QuanMol Tech is establishing a new standard for in-silico drug discovery with its AI-powered precision drug design platform that determines optimal compounds from structural information over traditional trial-and-error based processes.
Quantum Bridge Technologies
FUNDRAISING
Quantum Bridge Technologies develops and commercializes cryptographic solutions to protect government and enterprise clients against quantum computer attacks.
resistanceBio
FUNDRAISING
resistanceBio is pioneering a new therapeutic modality to overcome cancer drug resistance by mapping how cancer will evolve to resist therapies using billions of cells in long-term evolution.
Rocket Propulsion Systems
FUNDRAISING
Rocket Propulsion Systems manufactures affordable and scalable rocket engines and space vehicles that dramatically improve the economics of small and medium payload launch operations.
Serinus Bio
FUNDRAISING
Serinus Bio is designing precision medicine drugs to overcome cancer treatment resistance with its active-learning AI platform that identifies shared vulnerabilities across resistant patient populations that are otherwise too small or insular to motivate drug development programs.
Sinovia Technologies
FUNDRAISING
Sinovia manufactures printed light film to create next-generation interfaces for smart products using newspaper printing techniques and a proprietary materials technology.
SleepScore Labs
FUNDRAISING
SleepScore Labs provides data and insights to improve health through better sleep.
Soliyarn
FUNDRAISING
Soliyarn creates smart fabrics sustainably, using a variety of functional coatings that are applied with a proprietary chemical vapor deposition process (CVD). The process preserves the innate characteristics of the fabric and eliminates the use of water in the finishing processes.
Strayos
FUNDRAISING
Strayos helps Mining and Cement companies sustainably extract raw minerals and materials by providing machine vision sensing and a visual AI platform to optimize the Drilling, Blasting, and Crushing process to improve the mine’s efficiency, profitability, and sustainability.
SURF Security
FUNDRAISING
SURF provides secure, productive, and agile browsing experiences for organizations by consolidating multiple endpoint security tools using the SURF Zero-Trust Browser that securely connects users to their web apps.
Synapbox
FUNDRAISING
Synapbox helps brands test their messaging and creative content by conducting automated interviews and collecting biometric and rational feedback from consumers online.
Tezcat Biosciences
FUNDRAISING
Tezcat Biosciences is developing a receptor-independent drug delivery technology to provide treatment alternatives for patients harboring RAS-activated cancers.
Vector Bioscience
Vector Bioscience is developing a machine learning supported RNA delivery platform for any existing cargo, enabling precision-targeted delivery to tumors with controlled release, driving improved efficiency and minimized side effects.
VESSL AI
FUNDRAISING
VESSL AI accelerates AI development at scale by building robust MLOps infrastructure.
Vivtex
Vivtex is enabling the development of new oral drugs for medications that currently require painful, inconvenient needle injections using its high-throughput, gut-on-a-chip platform supported by its proprietary AI algorithms and formulations.
Vody
Vody empowers e-commerce companies to boost sales and save costs by enhancing recommendation systems and surfacing relevant content using multimodal ML classification and generative models that harness diverse data sets.
ZORDI
FUNDRAISING
Zordi uses AI and intelligent robots to develop automated greenhouses with the goal of feeding the world with high-quality, sustainably-grown produce. Currently operating two farms in New York and New Jersey.
MISSION
To transform breakthrough science into societal impact. We seek to advance human welfare by supporting founders of science and technology-based startups.
PROGRAM
Founded at New York University’s Stern School of Business, Endless Frontier Labs guides founders through a performance-based mentoring process over the course of nine months. Endless Frontier Labs is open to pre-Series A science and technology startups. The program is suitable for founders from around the world seeking connections to the thriving New York startup ecosystem or U.S. markets. Founders are not required to have a New York University affiliation and do not have to relocate to New York. The program is completely free for participating founders and does not take any equity in startups.
PARTNERS
EFL is supported by the program’s Founding Partners Elizabeth Elting, Stan Moss, and Glenn Krevlin. EFL’s corporate partners support the program and its participating startups through a variety of services.